Advantage Growth Fund

Advantage Growth Fund

The Advantage Growth Fund was a £17.5m fund established in 2003 as part of the UK government Regional Venture Capital Fund initiative to invest in West Midlands based small and medium sized enterprises.

The Fund, which was able to make initial investments of up to £250,000, is now closed. The Fund supported 45 businesses across a wide range of sectors and stages, including start-ups and management buy-outs. Midven assisted those companies to raise additional funding, over and above that invested by the Advantage Growth Fund, in excess of £80m.

The Fund achieved particular success in helping grow businesses with strategic value. Notable successes included:

  • Scriptswitch (36 times return on investment)
  • Allinea (21 times return on investment)
  • Dynamic Change (8 times return on investment)
  • Midland Industrial Glass (7 times return on investment)
  • Quantum Risk Management (7 times return on investment)

Generating these return levels demonstrated that our approach of working closely with companies delivers long-term growth and value.

The Fund was created with funding from the DTI Small Business Service (now the Department for Business Energy and Industrial Strategy), the European Investment Fund, Barclays Bank, the Royal Bank of Scotland, HSBC, the universities of Warwick, Coventry, Aston, Birmingham and Birmingham City and Midven.

The Fund was managed by Tony Stott, Roger Wood and Surjit Kooner.

Fund Facts

Current As At: 1st April 2020

Fund Amount £17.5m

>£80m Leverage, 46 Investments

1 Companies

Fund Managers

Associated Investments

Relevant News

Midven Sells Employee Optimisation Software Company Silver Lining Solutions

12th April 2017 Third exit in three months for Birmingham-based venture capitalists Venture capital specialists…

read more

Venture Capital Specialists Midven follows £18M Allinea Exit with sale of Prolojik

  2 March 2017 Midlands’ leading “patient venture capital”firm ushers Allinea and Prolojik into new opportunities…

read more

Cytox Announces Participation In Insight Alzheimer’s Study

13 October 2015 Participation will aid comparison of SNP genotyping with biomarker status Cytox Ltd,…

read more

Cytox Signs Research Agreement with AIBL and Partner Organisations

Collaboration Will Contribute To Further Refinement Of Diagnostic SNPs For Alzheimer’s Disease 1 June 2015:…

read more

Midven Portfolio Company Talecom Makes It a Hat-Trick of Awards

21 March 2013 Talecom Limited makes it a hatrick of awards and wins Motorola Solutions’…

read more

Glass firm's management team scoops exit award

April 25, 2012 GLASS FIRM’S MANAGEMENT TEAM SCOOPS EXIT AWARD The management team of a…

read more

Case Studies

Case Study - Simworx

Summary: Nature of Business: Entertainment Simulators Year of Entry: 2008 Amount Invested: £552,682 Year of…

read more

Case Study - Midland Industrial Glass

Summary: Nature of Business: Glass processing Year of Entry: 2005 Amount Invested: £200,000 Year of…

read more

Case Study - Dynamic Change

Summary: Nature of Business: Risk Management Software Year of Entry: 2003 Amount Invested: £100,000 Year…

read more

Case Study - ScriptSwitch

Summary: Nature of Business: Software for NHS Year of Entry: 2002 Amount Invested: £254,642 Year…

read more
Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now